Baby Formula NEC Lawsuit
This MDL consolidates lawsuits against Abbott and Mead Johnson alleging their cow's milk-based infant formulas cause necrotizing enterocolitis (NEC), a devastating intestinal disease in premature babies. Research shows human milk reduces NEC risk by approximately 50%.
Key Takeaways
- NEC is the most common serious GI disease in newborns—it can be fatal or cause lifelong complications
- Cochrane review (2024) found human milk reduces NEC risk by ~50% compared to formula (high certainty evidence)
- About 7% of very low birth weight infants develop NEC—prematurity is the primary risk factor
- Abbott settled the first bellwether trial mid-trial in July 2024; no global settlement announced
- Lawsuits allege manufacturers knew the risk but failed to warn parents and healthcare providers
Key Facts (May 2026)
| Pending Lawsuits | 797 cases in federal MDL |
| Condition Alleged | Necrotizing Enterocolitis (NEC) |
| Defendants | Abbott Laboratories, Mead Johnson (Reckitt) |
| Products at Issue | Similac, Enfamil preterm formulas & fortifiers |
| Population Affected | Premature/low birth weight infants |
| Bellwether Status | First trial settled (Abbott, July 2024) |
| Global Settlement | Not announced as of May 2026 |
| Presiding Judge | Hon. Rebecca R. Pallmeyer |
| Court | N.D. Illinois (Chicago) |
| Can You Still File? | Yes, lawsuits are being filed |
Case Growth in 2025
Families continue to file lawsuits after learning about the link between cow's milk formula and NEC in premature infants. Case count has grown 26% since January 2025.
Source: JPML MDL Statistics Reports, January 2025-May 2026
1 What Is This Lawsuit?
The Abbott/Mead Johnson NEC MDL consolidates lawsuits from families of premature infants who developed necrotizing enterocolitis (NEC) after being fed cow's milk-based infant formulas, including Similac and Enfamil products.
The Core Allegation
Plaintiffs allege Abbott and Mead Johnson knew that cow's milk-based formulas significantly increase NEC risk in preterm infants compared to human milk, but failed to adequately warn parents and healthcare providers about this risk.
The Science
A 2024 Cochrane systematic review—the highest level of medical evidence—found that donor human milk reduces NEC risk by approximately 50% compared to formula (high certainty evidence based on 12 trials).
This is an emotionally devastating litigation involving the most vulnerable patients—premature babies in NICUs. Claims include failure to warn, negligence, and product liability. Families seek compensation for medical expenses, wrongful death, and the profound suffering caused by NEC.
2 What Is Necrotizing Enterocolitis (NEC)?
Medical Emergency
NEC is the most common, serious gastrointestinal disease affecting newborn infants. Healthcare providers consider NEC a medical and surgical emergency that requires immediate intervention.
In NEC, the intestinal tissue becomes inflamed and begins to die (necrosis). In severe cases, the intestinal wall can perforate (develop holes), allowing bacteria to leak into the abdomen and bloodstream, causing life-threatening infection.
Who Is at Risk?
The primary risk factor is prematurity and low birth weight. According to NICHD:
- All infants born preterm (<37 weeks) or with low birth weight (<5.5 lbs) are at increased risk
- The smaller the infant or the more premature, the greater the risk
- About 7% of very low birth weight infants develop NEC
- About 9% of cases occur in full-term infants (often with other conditions)
NEC Staging (Bell System)
Stage 1: Suspected NEC
Bloody stools, lethargy, slow heart rate, unstable temperature, mild abdominal bloating, vomiting
Stage 2: Definite NEC
Stage 1 symptoms plus reduced platelets, no bowel sounds, abdominal pain, gas in intestinal walls
Stage 3: Advanced NEC
Stages 1-2 plus apnea, low blood pressure, inflammation, possible intestinal perforation
3 Consequences of NEC
Mortality
- NEC is a leading cause of infant mortality
- Mortality can exceed 20-30% in severe cases requiring surgery
- Many cases involve wrongful death claims
Long-Term Complications
- Short bowel syndrome—requires long-term IV nutrition
- Multiple surgeries including bowel resections
- Neurodevelopmental delays and growth problems
4 The Scientific Evidence
Cochrane Review (2024) — Highest Level Evidence
| Key Finding | Human milk reduces NEC risk by ~50% vs formula |
| Risk Ratio | 0.53 (95% CI: 0.37-0.76) |
| Evidence Quality | High certainty (GRADE assessment) |
| Data Source | 12 randomized trials, 2,296 infants |
PMID: 39239939 — Published September 2024
Why Human Milk Protects
Important Context
Formula remains medically necessary when human milk isn't available. Not all formula-fed preterm infants develop NEC, and NEC has multiple contributing factors. The issue in this litigation is whether manufacturers adequately warned about the increased risk.
5 Products at Issue
A Abbott Products
- Similac Special Care (preterm hospital use)
- Similac NeoSure (post-discharge)
- Abbott human milk fortifiers
M Mead Johnson Products
- Enfamil Premature (hospital use)
- Enfacare (post-discharge)
- Mead Johnson human milk fortifiers
6 Litigation Developments
July 2024: First Bellwether Settlement
Abbott Laboratories settled the first bellwether case mid-trial before a verdict was reached. The financial terms were not publicly disclosed. This settlement was significant as the first resolution in the MDL but did not establish binding precedent.
MDL Created: Early 2022
JPML consolidated cases in the Northern District of Illinois before Judge Pallmeyer
Ongoing Trials
Additional bellwether trials have proceeded, with some verdicts against Mead Johnson
No Global Settlement Yet
As of March 2026, no mass settlement program has been announced
7 Who May Qualify
Families may be eligible to file a lawsuit if their child meets these criteria:
Born Prematurely
Infant was born before 37 weeks gestation, especially very low birth weight (<1,500 grams)
Fed Cow's Milk Formula
Was fed Similac, Enfamil, or similar cow's milk-based preterm formula or fortifier in the NICU
Diagnosed with NEC
Infant was diagnosed with necrotizing enterocolitis during NICU stay
Have Medical Documentation
Medical records document the formula feeding and NEC diagnosis
8 Frequently Asked Questions
Is this about the 2022 Abbott formula recall?
Does this mean formula is dangerous for all babies?
Why do hospitals still use formula if human milk is safer?
What compensation might be available?
Is it too late to file a lawsuit?
Who are the defendants?
Sources & References
7 sources citedJudicial Panel on Multidistrict Litigation (JPML) — Official MDL statistics
NICHD Necrotizing Enterocolitis — NIH disease information
Cochrane Review (2024) — Donor human milk vs formula for NEC prevention (PMID: 39239939)
CDC NCHS Birth Statistics — US preterm birth data
WHO Preterm Birth Fact Sheet — Global prematurity data
AAP Policy Statement (2017) — Donor human milk for high-risk infants
Court records and JPML case statistics. Data current as of May 2026.
Attorney Advertising. The information on this page is provided for general informational purposes only and does not constitute legal advice. No attorney-client relationship is created by accessing or using this content.
Every case is unique, and results depend on the specific facts and circumstances involved. Past settlement amounts and case outcomes do not guarantee similar results in your case. If you believe you have a legal claim, you should consult with a licensed attorney in your jurisdiction who can evaluate your specific situation.